Found: 37
Select item for more details and to access through your institution.
Development of a process map for the delivery of virtual clinical pharmacy services at Odette Cancer Centre during the COVID-19 pandemic.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 650, doi. 10.1177/1078155221991202
- By:
- Publication type:
- Article
Recognizing the potential for copper-related toxicities from liposomal daunorubicin--cytarabine.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Cancer patient experience of telephone clinics implemented in light of COVID-19.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 644, doi. 10.1177/1078155221990101
- By:
- Publication type:
- Article
Fibroblast growth factor receptor (FGFR) inhibitors: A review of a novel therapeutic class.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 702, doi. 10.1177/1078155220983425
- By:
- Publication type:
- Article
Applications and challenges in therapeutic drug monitoring of cancer treatment: A review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 693, doi. 10.1177/1078155220979048
- By:
- Publication type:
- Article
Comparison of the effect of different methods of cyclosporine infusion on transplant-related outcomes in allogeneic transplant recipients.
- Published in:
- 2021
- By:
- Publication type:
- Letter
NEPA as antiemetic prophylaxis after failure of 5HT<sub>3</sub>-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 609, doi. 10.1177/1078155220929409
- By:
- Publication type:
- Article
Prescriber and pharmacist understanding of revised Rhode Island pain management regulations.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 601, doi. 10.1177/1078155220929057
- By:
- Publication type:
- Article
Impact of clinical pharmacy in oncology and hematology centers: A systematic review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 679, doi. 10.1177/1078155220976801
- By:
- Publication type:
- Article
A single-center qualitative study evaluating the safety and efficacy of a pharmacist-driven protocol for high-dose methotrexate management.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 588, doi. 10.1177/1078155220927455
- By:
- Publication type:
- Article
A drug repositioning success: The repositioned therapeutic applications and mechanisms of action of thalidomide.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 673, doi. 10.1177/1078155220975825
- By:
- Publication type:
- Article
Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 658, doi. 10.1177/1078155220973737
- By:
- Publication type:
- Article
Tacrolimus induced pseudogout following allogeneic hematopoietic cell transplant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 771, doi. 10.1177/1078155220951241
- By:
- Publication type:
- Article
Pazopanib-related secondary polycythemia in metastatic myxofibrosarcoma: A case report and review of the literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 766, doi. 10.1177/1078155220950440
- By:
- Publication type:
- Article
Development of carpal tunnel syndrome in association with checkpoint inhibitors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 764, doi. 10.1177/1078155220950430
- By:
- Publication type:
- Article
Monoclonal antibody extravasations: Two case reports and literature review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 761, doi. 10.1177/1078155220950005
- By:
- Publication type:
- Article
Breastfeeding in a patient with chronic myeloid leukemia during tyrosine kinase inhibitor therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 756, doi. 10.1177/1078155220948942
- By:
- Publication type:
- Article
Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 751, doi. 10.1177/1078155220948934
- By:
- Publication type:
- Article
Rituximab desensitization in pediatric acute lymphoblastic leukemia with severe anaphylaxis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 747, doi. 10.1177/1078155220948596
- By:
- Publication type:
- Article
Tofacitinib for treatment in immune-mediated myocarditis: The first reported cases.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 739, doi. 10.1177/1078155220947141
- By:
- Publication type:
- Article
A second administration of glucarpidase in a different cycle of high-dose methotrexate: Is it safe and effective in adults?
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 734, doi. 10.1177/1078155220946464
- By:
- Publication type:
- Article
Bullous pemphigoid in elderly woman affected by non-small cell lung cancer treated with pembrolizumab: A case report and review of literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 727, doi. 10.1177/1078155220946370
- By:
- Publication type:
- Article
Severe rhabdomyolysis induced by possible drug–drug interaction between Ribociclib and Simvastatin.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 722, doi. 10.1177/1078155220945365
- By:
- Publication type:
- Article
New onset diabetes with ketoacidosis following nivolumab immunotherapy: A case report and review of literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 716, doi. 10.1177/1078155220943949
- By:
- Publication type:
- Article
Gefitinib induced severe hyponatremia: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 711, doi. 10.1177/1078155220942302
- By:
- Publication type:
- Article
A real-world data approach to determine the optimal dosing strategy for pembrolizumab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 635, doi. 10.1177/1078155220929756
- By:
- Publication type:
- Article
Educational needs of oncology pharmacists: A survey by the International Society of Oncology Pharmacy Practitioners.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 623, doi. 10.1177/1078155220929754
- By:
- Publication type:
- Article
Comparing the clinical efficacy and safety of abiraterone and enzalutamide in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 614, doi. 10.1177/1078155220929414
- By:
- Publication type:
- Article
Thyroid cancer risk factors and Pakistani University students' awareness towards its preventive practice.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 570, doi. 10.1177/1078155220925166
- By:
- Publication type:
- Article
Predictors of increased melphalan exposure correlate with overall survival, nonrelapse mortality, and toxicities in patients undergoing reduced-intensity allogeneic stem cell transplantation with fludarabine and melphalan.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 579, doi. 10.1177/1078155220927436
- By:
- Publication type:
- Article
Impact of pharmacist-managed immune checkpoint inhibitor toxicities.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 596, doi. 10.1177/1078155220928407
- By:
- Publication type:
- Article
A clinical approach to non-neutropenic fever in children with cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 560, doi. 10.1177/1078155220925161
- By:
- Publication type:
- Article
Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 541, doi. 10.1177/1078155220924075
- By:
- Publication type:
- Article
Dosing errors in total parenteral nutrition prescriptions at a specialized cancer care hospital of Lahore: The role of clinical pharmacist.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 531, doi. 10.1177/1078155220923014
- By:
- Publication type:
- Article
Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 555, doi. 10.1177/1078155220924719
- By:
- Publication type:
- Article
Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 547, doi. 10.1177/1078155220924088
- By:
- Publication type:
- Article
When is it acceptable to allow a terminal patient to die? Pharmacy students' views from a London University.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 521, doi. 10.1177/1078155220921546
- By:
- Publication type:
- Article